Back

The LIPL study lipid panels and platelet activity in coronary heart disease

27 August 2022 (13:15 - 13:55)
Organised by:
Congress Presentation Part of: Novel biomarkers in cardiovascular disease Platelets, Haemostasis, Coagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Edita Pogran

Ottakring Clinic, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
RNA-sequencing reveals significant differences in the inflammatory response of iPSC-derived endothelial cells from ACS patients and healthy controls
Doctor E. Straessler (Berlin, DE)
Abstract Slides
Presentation thumbnail
Autoantibodies may predict the neurological severity of patients with Wilson disease
Mrs C. Eyileten (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Ceramide-based lipid profiles and the prevalence of type 2 diabetes differ between patients with coronary artery disease and those with peripheral artery disease
Doctor A. Leiherer (Feldkirch, AT)
Abstract Slides
Presentation thumbnail
Circulating CD31 reflects endothelial activity and is associated with a lower risk for cardiovascular complications
Associate Professor A. Edsfeldt (Malmo, SE)
Abstract Slides
Presentation thumbnail
Immunogenic lipid oxidation by oxidative stress in young people and the risk of early atherogenic endotelial dysfunction
Assistant Professor M. Bezna (Craiova, RO)
Abstract Slides

Access the full session

Session thumbnail
Novel biomarkers in cardiovascular disease

The Event

Event poster

ESC Congress 2022

27 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Dynamic lipoprotein(a) changes in acute coronary syndromes: implications for accurate cardiovascular risk assessment
20 March 2026
thumbnail
Congress Presentation
Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention
1 September 2024
thumbnail
Congress Presentation
Relationship between blood lipid panel with body mass, smoke exposure, dyspnea, physical activity, and quality of life in patients with dyslipidemia
26 April 2024
thumbnail
Congress Presentation
Platelet-specific deletion of acetyl-CoA carboxylase 1 decreases phospholipid content and impairs platelet functions
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources